XNK Therapeutics to present at ABGSC Private Companies Seminar on December 6
For more information, please contact: For more information, please contact: Johan Liwing, CEO, XNK TherapeuticsTel: +46 706 70 36 75 E-mail:[email protected] This information was brought to you by Cisionhttp://news.cision.com https://news.cision.com/xnk-therapeutics-ab/r/xnk-therapeutics-to-present-at-abgsc-private-companies-seminar-on-december-6,c3463308 The following files are available for download:
Comunicato Precedente
Comunicato Successivo
For more information, please contact:
Johan Liwing, CEO, XNK Therapeutics
Tel: +46 706 70 36 75
E-mail: [email protected]
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/xnk-therapeutics-ab/r/xnk-therapeutics-to-present-at-abgsc-private-companies-seminar-on-december-6,c3463308
The following files are available for download:
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
;




